Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Floseal for Anterior Epistaxis in HHT
NCT02638012Completed
- Sponsor
- Unity Health Toronto
- Start
- Dec 2015
- Primary completion
- Oct 2019
- Modality
- Implantable Devices, Transdermal Patches, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of gelatin + thrombin in hereditary hemorrhagic telangiectasia (HHT) and epistaxis, sponsored by Unity Health Toronto. Primary endpoint: Epistaxis Severity Score at 1 month. Started Dec 2015; status: completed.
02
Drugs
gelatin + thrombin
03
Conditions
hereditary hemorrhagic telangiectasia (HHT)epistaxis
Beyond the preview
Go deeper on NCT02638012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02638012.